For decades, the molecular conversations between proteins and DNA — the fleeting contacts that decide a cell's fate — have slipped through the fingers of even the most sophisticated laboratory methods. A new technique called D&D-seq, published in Cell, transforms DNA itself into a living record of these interactions, capturing them at the resolution of a single cell. By chemically inscribing the moment a regulatory protein touches the genome, researchers can now read the regulatory biography of individual cells rather than the blurred average of millions — a shift that carries profound implica
D&D-seq Maps DNA-Protein Interactions in Single Cells Using Base Editing
Cobertura Relacionada
GPS tracking reveals a northern boobook owl flew nonstop 1,848km from Japan to the Philippines in 36 hours, challenging …
Genetic Literacy Project · Aug 25 CRISPR-edited tomatoes yield 6x more fruit in cold conditions, study findsResearchers used CRISPR gene-editing to create tomato varieties that produce fruit reliably in cold conditions, yielding…
Space · Aug 25 Astronauts Complete ISS Antenna Replacement in Second SpacewalkNASA astronaut Anil Menon and ESA's Sophie Adenot conduct a spacewalk to replace a failed communications antenna on the …
Mental Floss · Aug 25 Test Your Knowledge: 25 Trivia Questions Spanning History and General FactsMental Floss presents 25 trivia questions testing readers' knowledge of August 25 historical events, general August fact…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
Scientific advancement in genetic research has no direct geopolitical implications; this is a biotechnology methodology paper with potential future applications in medical research.
Lente Económico
D&D-seq base-editing technology enables single-cell mapping of DNA-protein interactions, advancing precision diagnostics and drug development in biotechnology and pharmaceutical sectors.
Consumers may benefit from improved disease diagnostics and personalized medicine approaches, though impacts are indirect and long-term as this is foundational research enabling future clinical applications.
Potential regulatory frameworks needed for single-cell genomic analysis standards; FDA may develop guidance for diagnostic tools using this technology; increased R&D tax incentives likely to support biotech innovation in this space.